Summary tables comparing neoplastic disorders: Difference between revisions
From haematologyetc.co.uk
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
!colspan="5" style = "font-size:100%; color: navy; text-align:center; background:#DEE0DE;"|'''Immunophenotype LPD''' | !colspan="5" style = "font-size:100%; color: navy; text-align:center; background:#DEE0DE;"|'''Immunophenotype LPD''' | ||
|- | |- | ||
|colspan="1" style = "font-size:80%; width: | |colspan="1" style = "font-size:80%; width: 20%; |'''Marker''' | ||
|colspan="1" style = "font-size:80%; width: 20%; |'''CLL''' | |colspan="1" style = "font-size:80%; width: 20%; |'''CLL''' | ||
|colspan="1" style = "font-size:80%; width: 20%; |'''MCL''' | |colspan="1" style = "font-size:80%; width: 20%; |'''MCL''' | ||
Revision as of 00:01, 22 June 2023
| Immunophenotype LPD | ||||
|---|---|---|---|---|
| Marker | CLL | MCL | FL | MZL |
| κ/λ | 40:80 wk | >80 | 40:80 | >80 |
| FMC7 | 20:40 wk | 40:80 | 40:80 | |
| CD5 | >80 | >80 longer | <5% | |
| CD10 | 5-20 | 5-20 | >80 Stg | |
| CD11C | 20:40 wk | 20:40 wk | <5% | |
| CD19 | >80 | >80 | 40:80 | |
| CD20 | >80 | >80 | >80 | |
| CD23 | >80 | 5-20 | 40:80 | |
| CD25 | 20:40 wk | 20:40 wk | 5-20 wk | |
| CD38 | 20:40 | >80 | >80 | |
| CD43 | >80 | 40:80 | <5% | |
| CD79b | >80 wk | >80 | >80 | |
| CD103 | <5% | <5% | <5% | |
| CD138 | <5% | <5% | <5% | |
| CD200 | >80 | <5% | <5% | |
Key to table:
Key to colour code Click for link
Key to expression code Click for link